IQVIA Shares Surge as Quarterly Earnings Outpace Market Expectations

Shares of IQVIA Holdings climbed 8.3% to $230.99 in premarket trading after the biopharmaceutical services provider reported second-quarter revenue of $4.37 billion. This performance surpassed analyst projections of $4.3 billion, signaling a robust recovery for the company as it approaches its 52-week price high.

Today, 17:45· Money Talk· 725 reads

IQVIA Shares Surge as Quarterly Earnings Outpace Market Expectations

The company’s adjusted earnings reached $3.15 per share, comfortably beating the $3.03 forecast set by FactSet analysts. This growth is underpinned by a significant expansion in the firm’s contract pipeline, with net new bookings rising 19% compared to the same period last year.

IQVIA concluded the quarter with a record backlog of $34.2 billion. Management anticipates converting approximately $9.2 billion of this total into revenue over the coming twelve months, providing a stable outlook for the research organization's commercial outsourcing operations.

IQVIA Shares Surge as Quarterly Earnings Outpace Market Expectations

Comments (0)